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Background and purpose   Hydroxyapatite (HA) is widely used as 
a coating for uncemented total hip arthroplasty components. This 
has been suggested to improve implant ingrowth and long-term 
stability. However, the evidence behind the use of HA coating on 
femoral stems is ambiguous. We investigated survival of an unce-
mented, tapered titanium femoral stem that was available either 
with or without HA coating (Bi-Metric).
Patients and methods   The stem had been used in 4,772 total hip 
arthroplasties (THAs) in 4,169 patients registered in the Swedish 
Hip Arthroplasty Register between 1992 and 2009. 59% of the 
stems investigated were coated with HA and 41% were uncoated. 
Kaplan-Meier survival analysis and a Cox regression model with 
adjustment for age, sex, primary diagnosis, and the type of cup 
fixation were used to calculate survival rates and adjusted risk 
ratios (RRs) of the risk of revision for various reasons.
Results   The 10-year survival rates of the HA-coated version 
and the uncoated version were about equal when we used revision 
for any reason as the endpoint: 98% (95% CI: 98–99) and 98% 
(CI: 97–99), respectively. A Cox regression model adjusting for 
the covariates mentioned above showed that the presence of HA 
coating did not have any influence on the risk of stem revision for 
any reason (RR = 1.0, 95% CI: 0.6–1.6) or due to aseptic loosen-
ing (RR = 0.5, CI: 0.2–1.5). There was no effect of HA coating on 
the risk of stem revision due to infection, dislocation, or fracture.
Interpretation   The uncemented Bi-Metric stem showed excel-
lent 10-year survival. Our findings do not support the use of HA 
coating on this stem to enhance implant survival.

 
It is generally believed that coating of total hip arthroplasty 
(THA)  components  with  hydroxyapatite  (HA)  improves 
implant ingrowth and long-term stability. Thus, a large number 
of prostheses designed for uncemented hip arthroplasty are 
coated with HA. In Europe, some manufacturers mainly or 
exclusively market uncemented hip prostheses with such a 
coating.
The evidence behind the use of HA is ambiguous, how-
ever. Several reports on smaller series have described varying 
outcomes after the use of HA-coated cups or stems. Good or 
even excellent results were found after the use of some HA-
coated implants, with survival rates close to 100% when using 
revision or impending revision for aseptic loosening as the 
endpoint (Oosterbos et al. 2001, Capello et al. 2003, Shah et 
al. 2009). On the other hand, mediocre to obviously inferior 
results of HA-coated hip arthroplasty components have also 
been reported (Havelin et al. 2000, Reikerås and Gunderson 
2002, Cheung et al. 2005, Kim et al. 2006). A large Danish 
registry analysis on uncemented hip implants found that HA 
coating did not reduce the risk of revision in patients younger 
than 70 years of age (Paulsen et al. 2007). In a recent analysis 
based on data from the Swedish Hip Arthroplasty Register, we 
found that HA coating of acetabular cups could even increase 
the risk of revision due to aseptic loosening (Lazarinis et al. 
2010). 
In this study, we analyzed survival of uncemented femoral 
stems in the Swedish Hip Arthroplasty Register that were used 
either with or without HA coating. Our main hypothesis was 
that HA coating influences the risk of stem revision for any 
reason, which was our primary endpoint. Secondary endpoints 
were stem revision due to aseptic loosening, infection, frac-
ture, or dislocation.
Patients and methods
Sources of data and study population
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of our data. All orthopedic units in Sweden that perform total 
hip arthroplasty, both public and private, are included in the 
Register. All reoperations (secondary operation of the hip) and 
revisions (exchange or removal of any of the components) have 
been continuously reported by all operating units in Sweden 
since  1979.  From  1992  onwards,  implants  inserted  during 
THA have been linked to the personal ID number, and infor-
mation gathered includes the type of implant, fixation, and 
technical details such as HA coating. The Swedish ID number 
enables registration of changes of address and dates of emigra-
tion or death, information that is necessary in order to perform 
survival analyses. The Swedish Hip Arthroplasty Register has 
been repeatedly validated (Söderman et al. 2000, 2001).
The  only  uncemented  femoral  stem  that  was  available 
with or without HA coating (according to the Swedish Hip 
Arthroplasty Register) during the time period 1992–2009 was 
the Bi-Metric prosthesis (Biomet Inc., Warsaw, USA). This 
stem is an uncemented, tapered implant made of titanium alloy 
(Ti-6Al-4V) where the proximal third has a plasma-sprayed, 
titanium alloy porous coating with a mean pore size of 300 
μm. The distal part has a textured surface with a roughness 
of 6.9 μm. In the HA-coated version, the proximal, porous-
coated part of the stem is covered with a plasma-sprayed HA 
layer. The HA coating has a thickness of 40–70 mm, a crystal-
linity of 50–70%, and a purity of greater than 95%, although 
the manufacturer has stated that changes in the composition of 
the HA coating have been made over time. We identified 4,772 
THAs in 4,169 patients in whom the Bi-Metric femoral stem 
had been used. 
Statistics
Follow-up started on the day of primary THA and ended on 
the day of revision, death, emigration, or December 31, 2009, 
whichever  came  first.  Kaplan-Meier  survival  analysis  was 
performed on the entire study cohort with HA coating as the 
independent factor, and stem revision for any reason or due to 
aseptic loosening as the endpoints. The log-rank test (Mantel-
Cox) was used to investigate differences between groups, and 
p-values < 0.05 were considered significant.
A Cox proportional hazards model was applied in order 
to examine the influence of HA coating on the relative risk 
(RR) of stem revision, with 95% confidence intervals (CIs), 
adjusting for the covariates age (≤ 49, 50–59, 60–75, and > 75 
years), sex, primary diagnosis (primary osteoarthritis (OA) or 
other diagnoses), and type of cup fixation (cemented or unce-
mented). These covariates were entered into the regression 
model and risk ratios were calculated for each variable, mutu-
ally adjusted for all other covariates. Adjusted risk ratios were 
calculated for stem revision for any reason or due to aseptic 
loosening, infection, dislocation, or fracture. The assumption 
of proportional hazards was investigated by hazard function 
plots and log-minus-log plots of all covariates. There was no 
sign of insufficient proportionality in the hazard functions, 
and log-minus-log plots ran parallel for all covariates. 
The inclusion of both joints in bilaterally operated patients 
has been proposed to lead to dependency issues. Thus, we per-
formed a separate analysis of all joints (4,772 hips in 4,169 
individuals in the Cox regression model), and 4,169 joints 
after excluding the second hip in bilaterally operated patients. 
The results were not statistically significantly different when 
all hips or only 4,169 hips were included (data not shown). 
All analyses were performed using PASW software (version 
18.0).
Results
Characteristics of the study population
The numbers of males and females were similar. The largest 
number of THAs was found in the age group between 50 and 
59 years, and primary osteoarthritis was the most common 
preoperative diagnosis (Table 1). Different types of cemented 
and uncemented cups were combined with the stems (Tables 
2 and 3). By 2009, 72 (1.5%) of all 4,772 stems had been 
revised, 14 (0.3%) due to aseptic loosening, 28 (0.6%) due to 
fracture, 12 (0.3%) due to deep infection, and 8 (0.2%) due 
to dislocation. The mean follow-up time for all stems was 4.5 
Table 1. Characteristics of the 4,169 patients studied in the Swedish 
Hip Arthroplasty Register (1992–2009) 
   + HA  – HA  Total
   n   %    n   %     n   %
Sex     
  Male  1,290  53   735  42  2,025   49
  Female  1,131  47  1,013  58  2,144   51
Age (years)     
  0–49   497  20   378  22   875  21
  50–59  1,005  42   691  39  1,696  41
  60–75   795  33   600  34  1,395   33
  > 75   124  5   79  5   203   5
Primary diagnosis     
  Primary OA  2,140  88  1,470  85  3,610   87
  Other   279  12   265  15   544   13
In 17 hips (15 patients), the primary diagnosis was unknown or not 
reported to the register. In bilaterally operated patients, age and 
diagnosis at the time of the first operation were used to calculate 
frequencies. The category “Other” under “Primary diagnosis” includes 
the diagnoses of rheumatoid arthritis and related disorders, cervical 
neck fracture, pediatric hip disease, and further diagnoses.
Table 2. Distribution of cemented and uncemented cups
   Stems 
   + HA  – HA  Total
   n   %    n   %     n   %
Cemented   1,482   53   809   41  2,291  48
Uncemented  1,318  47  1,163  59  2,481  52
Total  2,800  100  1,972  100  4,772  100Acta Orthopaedica 2011; 82 (4): 399–404  401
(SD 4.4) years—4.8 (SD 4.0) years for the HA-coated stems 
and 4.0 (SD 4.8) years for the uncoated stems.
Risk of stem revision for any reason
Kaplan-Meier  analysis  showed  a  similar  10-year  survival 
of 98% (CI: 98–99) for the HA-coated stems and 98% (CI: 
97–99) for the uncoated stems, with stem revision for any 
reason as the endpoint (Figure 1).
In a Cox regression model the crude RR of HA coating for 
the risk of stem revision for any reason was 0.99 (CI: 0.62–
1.6) without adjustment for covariates. Likewise, HA coating 
did not affect the risk of stem revision for any reason after 
adjustment for all other covariates, with an adjusted RR of 
1.0 (CI: 0.62–1.6) (Table 4). The only variable that had an 
influence on the risk of stem revision was the type of primary 
diagnosis: patients with diagnoses other than osteoarthritis ran 
a higher risk of stem revision (Table 4). This effect was mainly 
attributable to the facts that (1) patients operated for cervi-
cal neck fracture had a 5-fold increased risk of stem revision 
(CI: 2.1–13; p < 0.001), and (2) patients operated due second-
ary arthritis after pediatric hip disease had a 3-fold increased 
risk of stem revision (CI: 1.4–7; p = 0.006) when compared to 
patients with osteoarthritis. However, the numbers of revisions 
in these subgroups were small.
Risk of stem revision due to aseptic loosening or for 
other reasons
Kaplan-Meier analysis with HA coating as the independent 
factor and stem revision due to aseptic loosening as the end-
point showed that there was no difference in survival between 
stems coated with HA and uncoated stems. The 10-year sur-
vival was 99.8% (CI: 99.6–100) for the HA-coated stems and 
99.4% (CI: 98.8–100) for the uncoated stems (p = 0.2) (Figure 
2). When we adjusted for the covariates described above in 
the Cox regression model, the presence of HA coating did not 
affect the risk of stem revision due to aseptic loosening (RR = 
0.5, CI: 0.17–1.5) (Table 5).
The presence of HA coating was not found to have any influ-
ence on the the risk of stem revision due to infection, disloca-
tion, or fracture in a Cox regression model with adjustment 
for age, sex, primary diagnosis, and the type of cup fixation 
(Table 5).
Table 3. Distribution of the 7 most frequently used cups combined 
with the stem investigated
   Bi-Metric stem
   + HA  – HA
   n   %   n   %
Biomet Müller   410  15   112   6
Trilogy HA   330  12   252   13
Romanus HA   276  10   87   4
ZCA XLPE   272  10   170   9
Lubinus   262  9   79   4
Charnley    239  8   199   10
Romanus   136  5   243   12
Others   875  31   830   42
    2,800  100  1,972  100
Figure 1. Kaplan-Meier analysis with hydroxyapatite (HA) coating as 
the independent factor and stem revision for any reason as the end-
point. 10-year survival was 98.2% (CI: 97.6–98.8) for the HA-coated 
stems (red) and 97.7% (CI: 96.5–98.9) for the uncoated stems (black). 
The dashed lines represent 95% CIs for the 2 groups of stems (p = 
1.0).
Table 4. Relative risk (RR) of stem revision for any reason
Endpoint:   No. of  No. of  Adjusted RR a  p-value
Any reason   hips  revisions   (95% CI)
Coating        
  – HA  1,972  29  1.0 (ref) b
  + HA  2,800  43  1.0 (0.62–1.62)     1
Sex       
  Male  2,316  35  1.0 (ref)
  Female  2,456  37  0.89 (0.55–1.42)    0.6
Primary diagnosis       
  Primary OA  4,146  52  1.0 (ref) 
  Other c  609  20  2.77 (1.57–4.87)  < 0.001
Age       
   0–49  1,033  18  1.0 (ref) 
   50–59  1,977  27  1.16 (0.61–2.19)    0.7
   60–75  1,551  23  1.56 (0.77–3.17)    0.2
   > 75  211  4  2.41 (0.74–7.81)    0.1
Cup fixation       
  Cemented   2,291  32  1.0 (ref)
  Uncemented   2,481  40  0.94 (0.55–1.61)    0.8
a A Cox proportional hazards model was used where covariates 
(HA coating, sex, primary diagnosis, age, and type of cup fixation) 
were entered in the regression model and risk ratios were mutually 
adjusted for all covariates. Adjusted risk ratios (RRs) were calcu-
lated for revision for any reason.
b  ref: reference group.
c The category “Other” under ”Primary diagnosis” includes the diag-
nosis of rheumatoid arthritis and related disorders, cervical neck 
fracture, pediatric hip disease, and further diagnoses.402  Acta Orthopaedica 2011; 82 (4): 399–404
Discussion
Influence of HA coating on stem survival
The Bi-Metric stem is more widely used with HA coating than 
without, and this probably reflects that HA coating is believed 
to improve stem fixation and long-term stability. Indeed, a 
retrieval study on this stem found that there was more bone 
ingrowth around stems with HA coating than around those 
without (Coathup et al. 2001). However, a review of the litera-
ture on HA-coated uncemented femoral components failed to 
show an improvement in long-term stability (Chambers et al. 
2007). Similarly, a large Danish registry analysis on survival 
of HA-coated hip implants indicated that the femoral stem 
under investigation did not benefit from the use of HA coating 
(Paulsen et al. 2007). 
Randomized  studies  on  smaller  cohorts  have  reported 
medium-term results on other femoral stems available with or 
without HA coating in bilaterally operated patients. In sev-
eral studies, HA-coated titanium stems were implanted on one 
side and identical stems without an HA coating were inserted 
on the opposite side. It was found that HA coating did not 
influence radiological results or clinical performance of these 
stems in the medium-term (Kim et al. 2003, Park et al. 2003). 
Recently  published  meta-analyses  of  HA-coated  femoral 
stems in primary THA have also supported the notion that HA 
coating does not improve the survival of uncemented stems 
(Gandhi et al. 2009, Goosen et al. 2009).
Performance of the Bi-Metric stem
The tapered titanium femoral stem investigated in our study 
had excellent 10-year survival rates. Other studies on smaller 
numbers of patients who had received this stem have shown 
survival rates of between 95% and 100% at 10 years (Isaac 
et al. 2007, Davies et al. 2010). A low revision rate of the Bi-
Metric stem was also found in a large Finnish registry analy-
sis with 10-year survival of 96% based on aseptic loosening 
as the endpoint (Eskelinen et al. 2006). Similar results have 
been found in patients under the age of 55 years, i.e. a group 
with higher risk of early revision (Puolakka et al. 1999), and 
in patients over 55 years (Mäkelä et al. 2010).
Stress shielding due to distal load transfer between the stem 
and the femur can lead to excessive loss of proximal bone 
mineral density, especially in Gruen zones 1 and 7. This might 
result in implant subsidence, periprosthetic fractures, or loos-
ening (Otani and Whiteside 1992). Proximal bone loss around 
uncemented stems is a well-known phenomenon (Panisello et 
al. 2009, Pitto et al. 2010). A literature review of retrospec-
tive and prospective studies found that decreasing proximal 
bone density will persist for at least 1 year after implantation 
(Kröger et al. 1998). Several authors have pointed out that 
more or less pronounced periprosthetic proximal bone loss 
also occurs after the use of the Bi-Metric stem, after both pri-
mary and revision operations (Bodén et al. 2006, Sköldenberg 
et al. 2006, Adolphson et al. 2009). However, this phenom-
enon does not appear to influence the long-term performance 
of the stem.
We  found  that  the  risk  of  stem  revision  was  higher  in 
patients who received this implant due to cervical neck frac-
ture or due to secondary arthritis after pediatric hip disease.
These findings are in agreement with reports from the Swed-
Figure 2. Kaplan-Meier analysis with hydroxyapatite (HA) coating as 
the independent factor and stem revision due to aseptic loosening as 
the endpoint. 10-year survival was 99.8% (CI: 99.6–100) for the HA-
coated stems (red) and 99.4% (CI: 98.8–100) for the uncoated stems 
(black). The dashed lines represent 95% CIs for the 2 groups of stems 
(p = 0.23).
Table 5. Relative risk (RR) of stem revision due to aseptic loosening, 
infection, dislocation, or fracture 
   No. of  No. of   Adjusted RR a   p-value
Endpoint:   hips  revisions  (95% CI) 
Aseptic loosening        
   – HA  1,972  8  1.0 (ref) b 
  + HA  2,800  6  0.5 (0.17–1.5)  0.2
Infection       
   – HA  1,972  5  1.0 (ref)
  + HA  2,800  7  0.8 (0.25–2.6)  0.7
Dislocation       
   – HA  1,972  2  1.0 (ref)
  + HA  2,800  6  2.6 (0.52–13.2)  0.3
Fracture       
  – HA  1,972  10  1.0 (ref)
  + HA  2,800  18  1.2 (0.56–2.7)  0.6
a A Cox proportional hazards model was used to investigate the influ-
ence of HA coating on the relative risk (RR) of stem revision (with 
95% CIs), adjusted for the covariates age (0–49, 50–59, 60–75, 
and > 75), sex, primary diagnosis (primary osteoarthritis (OA) and 
other diagnoses), and type of cup fixation (cemented or unce-
mented). Adjusted risk ratios (RRs) were calculated for revision due 
to aseptic loosening, infection, dislocation, or fracture. 
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ish Hip Arthroplasty Register indicating that patients oper-
ated with a total hip prosthesis due to cervical neck fracture 
or secondary arthritis are at higher risk for prostheses loosen-
ing than those operated due to primary osteoarthritis (Swedish 
Hip Arthroplasty Register 2009).   
Confounding factors
Inferior  performance  of  uncemented  cups  compared  to 
cemented cups has been reported (Havelin et al. 2000, Hailer 
et al. 2010). Liner wear, osteolysis, loosening, and early revi-
sion of uncemented cups could affect the survival of the stems 
that were combined with uncemented cups. Because of this 
potential bias, the type of cup fixation (cemented or unce-
mented) was introduced as a covariate. However, the regres-
sion  model indicated that the  type of  cup fixation  did not 
influence the risk of revision of the stem for any reason as the 
endpoint (Table 4).
It  could  be  argued  that  the  association  of  one  group  of 
stems, either HA-coated or uncoated, with specific cups of 
inferior performance could distort stem survival in that group. 
For instance, the frequent use of cups with higher than aver-
age risk of osteolysis could lead to inferior long-term results 
on the stem side also. An increased amount of polyethylene 
debris  from  the  cups  could  finally  result  in  femoral  oste-
olysis and stem revision (Puolakka et al. 1999, Swedish Hip 
Arthroplasty  Register  2009).  However,  our  analysis  of  the 
various cups combined with the 2 types of Bi-Metric stems 
indicates that this was not the case. The distribution of cups 
combined with two types of stems varied substantially, but 
there seemed to be no obvious predominance of cups with 
inferior performance in any of the groups (Table 3). For exam-
ple, 15% of the HA-coated stems and 16% of the uncoated 
stems were combined with the Romanus cup, a cup associated 
with high revision rates (Swedish Hip Arthroplasty Register 
2009) mainly because of osteolysis and wear.
Several other covariates with a possible influence on stem 
survival were also investigated. The type of hospital of pri-
mary arthroplasty had no statistically significant influence on 
the risk of stem revision (data not shown). Some other pos-
sible confounding factors such as medications that are known 
to  influence  bone  metabolism  (e.g.  steroids,  non-steroidal 
anti-inflammatory drugs, bisphosphonates) were not recorded 
in the Swedish Hip Arthroplasty Register. The same applies to 
medical conditions that have an indirect influence on implant 
survival, such as overweight, diabetes mellitus, or disorders of 
lipid metabolism.
Statistical considerations 
Our findings indicate that there was excellent 10-year survival 
of the stem under investigation, with very few stem revisions 
recorded in the entire cohort (72 stems revised out of 4,772). 
Implicitly, the number of revisions is even smaller when sub-
groups of patients are analyzed, a problem that is illustrated 
by the analysis of the variable “preoperative diagnosis” (see 
above). Interpretation of our statistical analyses becomes even 
more difficult when the risk of stem revision due to aseptic 
loosening is considered, because only 14 stem revisions due 
to aseptic loosening occurred in the entire study cohort. Thus, 
absence of statistically significant effects of HA coating on 
stem survival does not necessarily imply that HA coating has 
no effect; i.e., the analysis is open to a type-II error. On the 
other hand, any potential differences between groups will be 
so small that their clinical relevance can be questioned.
Conclusion
Our results derived from registry data on 4,772 hips show that 
there is no difference in stem survival between uncemented 
Bi-Metric stems with and without HA coating. Our findings 
agree with the currently available literature on the subject, and 
do not support the idea that HA coating improves the long-
term survival of well-functioning uncemented femoral stems. 
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